https://scholars.lib.ntu.edu.tw/handle/123456789/528534
標題: | Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae | 作者: | Lee N.-Y. Huang W.-H. Tsui K.-C. PO-REN HSUEH Ko W.-C. |
公開日期: | 2011 | 卷: | 70 | 期: | 1 | 起(迄)頁: | 150-153 | 來源出版物: | Diagnostic Microbiology and Infectious Disease | 摘要: | For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem. ? 2011 Elsevier Inc. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/528534 | ISSN: | 0732-8893 | DOI: | 10.1016/j.diagmicrobio.2010.12.008 | SDG/關鍵字: | ciprofloxacin; cotrimoxazole; ertapenem; extended spectrum beta lactamase; fluconazole; imipenem; linezolid; meropenem; polypeptide antibiotic agent; timentin; aged; antibiotic sensitivity; article; bacteremia; bacterial metabolism; controlled study; drug choice; drug efficacy; drug response; drug treatment failure; enzyme synthesis; Escherichia coli; female; Gram negative sepsis; human; Klebsiella pneumoniae; major clinical study; male; mortality; observational study; outcome assessment; priority journal; retrospective study; survival rate; treatment duration; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Thienamycins; Treatment Outcome |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。